Xenical diet pill is a FDA approved prescription diet pill manufactured by Roche Laboratories.

It is a weight loss drug which works differently than other. While others diet pills such as Meridia, Phentermine and Acomplia act in the brain to suppress appetite, Xenical act in the stomach to stop the absorption of fats.

The Xenical principle of action for is different than other diet pills and is not an appetite suppressant. So, the side effects associated with these pills are also different.

Acomplia very effective weight loss medicine.

But apart for keeping a person free from excess weight, the diet pill Acomplia - multifunctional diet pill which also helps treat and control smoking binge.
Studies shown, there are nerve receptors called CB1receptors that exist in the brain and fat cells. These receptors urge the body to overeat and smoke. Acomplia works by targeting the CBI receptors and blocking the body's ability to receive signals that tells it to eat more.

It helps to normalize the EndoCannabinoid System thus making hunger and cigarette cravings more manageable. This blocking of signals results in weight loss and further improves the cardiovascular or metabolic risk factors in obese people and reduces their dependence on nicotine and helps them quit smoking.

More safe and effective phentermine alternative - order ACOMPLIA online - no prescription requried

Acomplia has been developed from the knowledge that cannabis smokers often experience extreme hunger pangs, which cannabis smokers refer to as 'the munchies'.

Acomplia works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these receptors by endoegenous cannabinoids, such as anadamide, increases appetite.

Filed for approval with the FDA in April 2005, it has encountered significant delays over the past two years. In February 2007, the company learnt that the FDA had extended their decision on whether or not to approve Acomplia by a further 3 months. Despite the repeated setbacks, analysts remain optimistic that it will eventually be approved in the US as an aid to weight loss.

Diet pills

available in several variable forms, including prescription drugs, over-the-counter drugs and herbal supplements.

A second name trademarked by Sanofi-Aventis, in addition to Acomplia, for rimonabant is Zimulti. You might see the drug adverted by either name, such as SR141716, Bethin, Monaslim, Remonabent, Riobant, Slimona and Rimoslim.

At this time it seems like Sanofi is likely to practice the name Zimulti in America and Acomplia in Europe. As of June, 2006, when rimonbant was approved for sale in Europe, "Acomplia" was indeed the name chosen for European sale and Zimulti for US sale.